Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tavneos
Pharma
EU regulators offer post-mortem of Tavneos withdrawal decision
EU regulators have outlined concerns that led to last week's formal revocation of the marketing authorization for the rare-disease med Tavneos.
Fraiser Kansteiner
Aug 14, 2026 11:04am
Amgen doesn't think Repatha's sales wins will stop anytime soon
Aug 4, 2026 4:01pm
Amgen submits analyses to FDA in bid for Tavneos hearing
Jul 24, 2026 10:50am
NEJM retracts article on pivotal study for Amgen’s Tavneos
Jun 30, 2026 10:57am
Europe's CHMP reverses endorsement of Amgen's Tavneos
Jun 26, 2026 11:07am
Amgen to file 3rd-party review of Tavneos data for FDA hearing
Jun 12, 2026 11:12am
